Black Rock Inc. Beam Therapeutics Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Black Rock Inc. holds 7,634,379 shares of BEAM stock, worth $184 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,634,379

Previous 6,705,626 13.85%

Holding current value

$184 Million

Previous $222 Million 19.26%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$21.22 - $32.66 $19.7 Million - $30.3 Million	928,753 Added 13.85%	7,634,379 $179 Million
Q1 2024 May 10, 2024	BUY	$23.46 - $45.07 $1.02 Million - $1.96 Million	43,583 Added 0.65%	6,705,626 $222 Million
Q4 2023 Feb 13, 2024	BUY	$17.69 - $30.76 $2.47 Million - $4.29 Million	139,388 Added 2.14%	6,662,043 $181 Million
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $3.95 Million - $5.58 Million	171,879 Added 2.71%	6,522,655 $157 Million
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $31.1 Million - $38.2 Million	1,060,104 Added 20.04%	6,350,776 $203 Million
Q1 2023 May 12, 2023	BUY	$30.15 - $48.79 $1.57 Million - $2.54 Million	52,031 Added 0.99%	5,290,672 $162 Million
Q4 2022 Feb 13, 2023	SELL	$36.73 - $51.6 $4.67 Million - $6.57 Million	-127,258 Reduced 2.37%	5,238,641 $205 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $8.36 Million - $14.8 Million	210,215 Added 4.08%	5,365,899 $256 Million
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $33.4 Million - $69.7 Million	1,117,493 Added 27.67%	5,155,684 $200 Million
Q1 2022 May 12, 2022	SELL	$53.73 - $82.16 $1.32 Million - $2.02 Million	-24,603 Reduced 0.61%	4,038,191 $231 Million
Q4 2021 Feb 10, 2022	BUY	$68.02 - $99.06 $36.9 Million - $53.8 Million	542,819 Added 15.42%	4,062,794 $324 Million
Q3 2021 Nov 09, 2021	BUY	$84.37 - $133.6 $29.2 Million - $46.2 Million	345,588 Added 10.89%	3,519,975 $306 Million
Q2 2021 Aug 11, 2021	BUY	$64.12 - $128.71 $204 Million - $409 Million	3,174,387 New	3,174,387 $409 Million

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.7B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account